| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Allarity Therapeutics (NASDAQ:ALLR) through any online brokerage.
Other companies in Allarity Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Allarity Therapeutics has a consensus price target of $11.00.
The stock price for Allarity Therapeutics (NASDAQ: ALLR) is $0.8701 last updated October 20, 2026 at 4:05 PM EDT.
There are no upcoming dividends for Allarity Therapeutics.
Allarity Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Allarity Therapeutics.
Allarity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
